Search

Hariprasad Prasad Gali

from Edmond, OK
Age ~50
Get Report
Also known as:
Hariprasad P Gali, Prasad Gali Hariprasad, Haripprasad Gali, Gali Hariprasad, Gali Haripprasad, Gale Hariprasad, Haripprasad Gati
Phone and address:
2328 NW 153Rd St, Edmond, OK 73013
Related to:
Ali M Jones, 38Kavitha Gali, 49Prasad G Hariprasad, 50Narsimhaswamy Gali
Connected to:
Angela S Gali, 63Armando G Gali, 37Bharath K Gali, 48Celestino J Gali, 56David Gali, 40Ginelle A Gali, 55Goldenberg Gali, 36Karthik Gali, 42Kathleen S Gali, 43Manuel D Gali, 75

Hariprasad Gali Phones & Addresses

  • 2328 NW 153Rd St, Edmond, OK 73013
  • College Station, TX
  • 1011 Southpark Dr, Columbia, MO 65201 (573) 441-1143
  • 1612 Anthony St, Columbia, MO 65201 (573) 441-1143
  • 1205 University Ave, Columbia, MO 65201

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Hariprasad Gali Photo 1

Associate Professor Of Research

View page
Location:
Oklahoma City, OK
Industry:
Higher Education
Work:
University of Oklahoma Health Sciences Center
Associate Professor of Research
University of Missouri
Associate Professor of Research
University of Oklahoma Health Sciences Center May 2008 - Jun 2018
Research Assistant Professor
University of Oklahoma Health Sciences Center May 2008 - Jun 2018
Director of Radiochemistry Laboratory, Research Imaging Facility
Lynntech, Inc. Feb 2002 - Sep 2007
Research Scientist
Education:
University of Missouri - Columbia 1996 - 1999
University of Hyderabad 1993 - 1995
P.g. College of Law, Basheerbagh 1990 - 1993
Skills:
Chemistry
Spectroscopy
Medicinal Chemistry
Drug Discovery
Research
In Vivo
Lifesciences
Radiochemistry
Digital Imaging
Molecular Imaging
Cancer
Microbiology
Biomedical Engineering
Languages:
English
Telugu
Hindi
Hariprasad Gali Photo 2

Hariprasad Gali

View page
Location:
Oklahoma City, Oklahoma Area
Industry:
Higher Education

Publications

Us Patents

Biomolecule Conjugation Strategy Using Novel Water-Soluble Phosphine-Based Chelating Agents

View page
US Patent:
6780397, Aug 24, 2004
Filed:
Aug 31, 1999
Appl. No.:
09/386657
Inventors:
Kattesh V. Katti - Columbia MO
Hariprasad Gali - Columbia MO
Wynn A. Volkert - Columbia MO
Assignee:
Curators of the University of Missouri - Columbia MO
International Classification:
A61K 4900
US Classification:
424 177, 424 169, 424 165, 568 13
Abstract:
This invention describes a novel strategy to produce phosphine-functionalized biomolecules (e. g. peptides or proteins) for potential use in the design and development of site-specific radiopharmaceuticals for diagnosis or therapy of specific cancers. Hydrophilic alkyl phosphines, in general, tend to be oxidatively unstable. Therefore, incorporation of such phosphine functionalities on peptide (and other biomolecule) backbones, without oxidizing the P centers, is difficult. In this context this discovery reports on a new technology by which phosphines, in the form of bifunctional chelating agents, can be directly incorporated on biomolecular backbones using manual synthetic or solid phase peptide synthesis methodologies. The superior ligating abilities of phosphine ligands, with various diagnostically (e. g. TC-99m) or therapeutically (e. g.

Gastrin Receptor-Avid Peptide Conjugates

View page
US Patent:
7060247, Jun 13, 2006
Filed:
May 2, 2001
Appl. No.:
09/847134
Inventors:
Timothy J. Hoffman - Columbia MO, US
Wynn A. Volkert - Columbia MO, US
Gary Sieckman - Ashland MO, US
Charles J. Smith - Columbia MO, US
Hariprasad Gali - Columbia MO, US
Assignee:
The Curators of the University of Missouri - Columbia MO
International Classification:
A61K 49/00
US Classification:
424 91, 424 111, 424 165, 424 169
Abstract:
A compound for use as a therapeutic or diagnostic radiopharmaceutical includes a group capable of complexing a medically useful metal attached to a moiety which is capable of binding to a gastrin releasing peptide receptor. A method for treating a subject having a neoplastic disease includes administering to the subject an effective amount of a radiopharmaceutical having a metal chelated with a chelating group attached to a-moiety capable of binding to a gastrin releasing peptide receptor expressed on tumor cells with subsequent internalization inside of the cell. A method of forming a therapeutic or diagnostic compound includes reacting a metal synthon with a chelating group covalently linked with a moiety capable of binding a gastrin releasing peptide receptor.

Rubidium-82 Generator Based On Sodium Nonatitanate Support, And Improved Separation Methods For The Recovery Of Strontium-82 From Irradiated Targets

View page
US Patent:
7476377, Jan 13, 2009
Filed:
Jul 19, 2004
Appl. No.:
10/894870
Inventors:
Teresia Moller - College Station TX, US
Todd Adams - Franklin TX, US
Alan Cisar - Cypress TX, US
Hariprasad Gali - College Station TX, US
Paul Sylvester - Waltham MA, US
Assignee:
Lynntech, Inc. - College Station TX
International Classification:
C01D 17/00
US Classification:
423598, 423 2, 423249, 252184, 502400
Abstract:
Sodium nonatitanate compositions, a method using the composition for recovery of Sr from irradiated targets, and a method using the composition for generating Rb. The sodium nonatitanate materials of the invention are highly selective at separating strontium from solutions derived from the dissolution of irradiated target materials, thus reducing target processing times. The compositions also have a very low affinity for rubidium, making it an ideal material for use as a Rb generator. Sodium nonatitanate materials of this type both improve the recovery of Sr and provide a safer, more effective Rb generator system.

Photosensitizers For Targeted Photodynamic Therapy

View page
US Patent:
8207211, Jun 26, 2012
Filed:
Feb 28, 2006
Appl. No.:
11/885241
Inventors:
Tim Wharton - Bryan TX, US
Hariprasad Gali - Edmond OK, US
Michael R. Hamblin - Revere MA, US
Assignee:
The General Hospital Corporation - Boston MA
Lynntech, Inc. - College Station TX
International Classification:
A61K 31/403
C07D 487/22
US Classification:
514410, 548417, 977734, 977904
Abstract:
The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.

Therapeutic And Diagnostic Targeting Of Cancers Cells With Tumor Homing Peptides

View page
US Patent:
20030232013, Dec 18, 2003
Filed:
Feb 20, 2003
Appl. No.:
10/371966
Inventors:
Gary Sieckman - Ashland MO, US
Wynn Volkert - Columbia MO, US
Leonard Forte - Columbia MO, US
Timothy Hoffman - Columbia MO, US
Hariprasad Gali - College Station TX, US
International Classification:
A61K051/00
A61K049/00
A61K048/00
A61K038/19
US Classification:
424/001690, 424/009322, 424/085100, 514/044000
Abstract:
The present invention provides methods of targeting breast cancer, prostate cancer, pancreatic cancer or melanoma cells using ST peptides. These methods permit both diagnostic evaluation and therapeutic intervention using appropriate conjugates.

Gastrin Receptor-Avid Peptide Conjugates

View page
US Patent:
20060067886, Mar 30, 2006
Filed:
Nov 4, 2005
Appl. No.:
11/267001
Inventors:
Timothy Hoffman - Columbia MO, US
Wynn Volkert - Columbia MO, US
Gary Sieckman - Ashland MO, US
Charles Smith - Columbia MO, US
Hariprasad Gali - Columbia MO, US
International Classification:
A61K 51/00
C07K 14/595
US Classification:
424001690, 530309000
Abstract:
A compound for use as a therapeutic or diagnostic radiopharmaceutical includes a group capable of complexing a medically useful metal attached to a moiety which is capable of binding to a gastrin releasing peptide receptor. A method for treating a subject having a neoplastic disease includes administering to the subject an effective amount of a radiopharmaceutical having a metal chelated with a chelating group attached to a moiety capable of binding to a gastrin releasing peptide receptor expressed on tumor cells with subsequent internalization inside of the cell. A method of forming a therapeutic or diagnostic compound includes reacting a metal synthon with a chelating group covalently linked with a moiety capable of binding a gastrin releasing peptide receptor.

212Bi Or 213Bi Generator From Supported Parent Isotope

View page
US Patent:
20070009409, Jan 11, 2007
Filed:
Jul 11, 2005
Appl. No.:
11/178741
Inventors:
Hariprasad Gali - College Station TX, US
Alan Cisar - Cypress TX, US
International Classification:
C01F 13/00
US Classification:
423002000
Abstract:
The invention includes a radionuclide generator having an ion exchange sorbent that comprises oxygen-containing functional groups grafted by organic linking groups to an inorganic oxygen-linked network and a parent isotope. For Bi or Bi generators, the parent isotope may be Ra, Ra or Ac. The surface area of the sorbent is preferably less than about 10 m/g and more preferably less than about 1 m/g. The exchange sorbent may be formed of any covalently bonded inorganic oxide that is capable of forming oxygen-linked networks. The oxidized functional groups may include sulfonato groups, may include moieties selected from —SOH, —SONa, —SOK, —SOLi, —SONHor may include moieties selected from —PO(OX)or —COOX, wherein X is selected from H, Na, K or NHor combinations thereof. A Bi or Bi generator process includes eluting Bi or Bi with an aqueous solvent that includes Ac or Ra or Ra on the above support medium.

Photosensitizers For Targeted Photodynamic Therapy

View page
US Patent:
20100184818, Jul 22, 2010
Filed:
Apr 15, 2008
Appl. No.:
12/598007
Inventors:
John Timothy Wharton - Bryan TX, US
Hariprasad Gali - Edmond OK, US
Michael R. Hamblin - Revere MA, US
Pawel Mroz - Boston MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
LYNNTECH, INC. - College Station TX
International Classification:
A61K 31/40
A61K 31/16
C12N 5/00
A61K 31/395
A61P 35/00
US Classification:
514410, 514616, 435375, 514183, 977734
Abstract:
The present invention provides photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.
Control profile
Hariprasad Prasad Gali from Edmond, OK, age ~50 Get Report